In female SLE patients, coronary artery calcification progression was associated with significant alterations in lipidomic and metabolomic profiles
PlexusDx providers are available for side effect consultations and can often address concerns with simple adjustmentsslowing your dose progression, switching formulations (injection versus oral), or recommending supportive medications
A monoclonal antibody that blocks activin type II receptors (ActRIIA/B) Dual Mechanism: In Adipose Tissue Blocks Activin E & GDF3 Lipid mobilization, Fat storage Goal: Decrease fat mass In Muscle Tissue Blocks Activin A & Myostatin Muscle growth Goal: Increase lean mass Key Clinical Trials BELIEVE Phase 2B IV Bimagrumab Semaglutide, quarterly dosing Ongoing Phase 2 SC Bimagrumab Tirzepatide, weekly dosing Why it matters
What Our Insurance Coverage Review Includes Before starting treatment, our team reviews your available insurance benefits to help you understand what your health plan may cover
doi.org/10.1038/nature03000 Dalmasso, G., et al
#Vestibular_neuritis, #Headache, #Palpitations, #Nausea To view or add a comment, sign in Early-Onset Atrial Fibrillation Is Not Benign A new nationwide study (Holt et al., Heart Rhythm, 2025) highlights the long-term risks of atrial fibrillation (AF) diagnosed at age 1845 years in patients without overt cardiovascular disease
